Mr. Ron Chapman II began his career as an officer in the U.S. Marine Corps and was deployed to combat in Afghanistan. He achieved the rank of Captain before transitioning to law.

He graduated from Loyola School of Law, where he received his Master of Laws (LL.M.) with a concentration in health care compliance.

He quickly established himself as a premier healthcare defense counsel, and is among the few attorneys to have achieved trial acquittals on behalf of clients charged with healthcare financial fraud or improper opioid prescribing.

Dr. Goldfarb has been an advocate of disenfranchised patients for decades, beginning with the AIDS epidemic and continuing through the pandemic.

She now actively combats vaccine misinformation through the organization, This Is Our Shot, which has redefined effective healthcare communication during the pandemic.

Dr. Shajahan is leading the conversation on healthcare misinformation and overcoming vaccine hesitancy through a unique blend of policy leadership and patient communication.

We discuss insights gleaned through her experiences, to learn how pandemic misinformation has led to vaccine hesitancy.

Dr. Rotenstein is a primary care physician, healthcare leader, and researcher whose work focuses on care delivery innovation, physician wellbeing, including burnout and depression, and gender issues in medicine.

We speak with Miss Leonard, Chief Operating Officer of MashupMD, a healthcare news aggregation site designed to improve the experience of reading healthcare information online.

MashupMD is the premier medical news aggregator that is completely free of data-tracking algorithms, and optimized for rapid and efficient access to the latest headlines in the medical world.

To learn more about MashupMD, please select the link below:

https://mashupmd.com/category/latest-headlines/

There are victims and then there are leaders. Dr. London was supposed to be the former, but she has become the latter. After enduring years of erroneous claims made against her by the DEA and the Maine medical licensing board, she decided to take matters into her own hands by attending law school.

Now in her last year of law school, she intends on becoming a leader in opioid policy and medical jurisprudence.

We interview Dr. Danielle Ofri, a pioneer in narrative medicine and the editor in chief of Bellevue Literary Review (BLR). She transformed BLR from an outgrowth of New York University to an independent publishing house. Now BLR celebrates its twentieth anniversary.

To learn more about BLR, please select the link below:

https://blreview.org/

We interview TameraLynn Stewart, one of the most successful chronic pain advocates in the country, who turned her experiences with pain and cancer into public health advocacy. She authored Senate Bill 57 (SB57), which proved to be landmark legislation, making Oklahoma one of the first states to reverse course on poorly conceived opioid policies - turning against restrictive prescribing practices and towards patient centric opioid policies.

To learn more about her law, SB57, please select the link below:

https://openstates.org/ok/bills/2021/SB57/

We discuss Dr. Cifu's book, Ending Medical Reversal, which discusses why we enact healthcare policies based on weak evidence or outright erroneous beliefs. We delve into policy reversals discussed in the book and those seen during the pandemic.

To purchase his book, co-authored with Dr. Vinay Prasad, please select the link below:

https://jhupbooks.press.jhu.edu/title/ending-medical-reversal

We also encourage you to read his article discussing the recent Aspirin policy reversal coming from the USPSTF:

https://www.medpagetoday.com/opinion/vinay-prasad/95281

Dr. Hochman leads a new initiative that provides sustainable, non-profit healthcare services to people experiencing homelessness (PEH). The initiative is part of SCAN Group, an organization known for innovative models of patient care.

Healthcare in Action seeks to prove that caring for PEH populations can be a sustainable, non-profit business model that optimizes both economic and clinical outcomes.

To learn more about Dr. Hochman's previous work in treating PEH populations, please select the link below:

https://www.sciencedirect.com/science/article/pii/S2213076421000403